Arterial Stiffness Is Related to Systemic Inflammation in Essential Hypertension
The acute phase–reactant high-sensitivity C-reactive protein, a marker of vascular inflammation and an atherosclerotic risk factor, is related to arterial stiffness in healthy subjects and in systemic vasculitis. To explore the relationship between markers of inflammation, interleukin-6 (IL-6), tumo...
Saved in:
Published in | Hypertension (Dallas, Tex. 1979) Vol. 46; no. 5; pp. 1118 - 1122 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
Philadelphia, PA
American Heart Association, Inc
01.11.2005
Hagerstown, MD Lippincott |
Subjects | |
Online Access | Get full text |
ISSN | 0194-911X 1524-4563 1524-4563 |
DOI | 10.1161/01.HYP.0000185463.27209.b0 |
Cover
Loading…
Abstract | The acute phase–reactant high-sensitivity C-reactive protein, a marker of vascular inflammation and an atherosclerotic risk factor, is related to arterial stiffness in healthy subjects and in systemic vasculitis. To explore the relationship between markers of inflammation, interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and high-sensitivity C-reactive protein with arterial stiffness, we studied untreated patients (n=78; 56% male; 47±1 years of age; mean±SEM) with essential hypertension. After overnight fast, augmentation index and pulse wave velocity were assessed noninvasively and related to plasma levels of inflammatory markers measured by ELISA. Pulse wave velocity was significantly related to plasma high-sensitivity C-reactive protein (r=0.31; P<0.001), TNF-α, (r=0.30; P<0.001) and IL-6 (r=0.21; P<0.05). There was also a relationship between heart rate–corrected augmentation index to high-sensitivity C-reactive protein (r=0.37; P<0.001), IL-6 (r=0.24; P<0.05), and TNF-α (r=0.19, P=0.06). High-sensitivity C-reactive protein was an independent predictor of pulse wave velocity and augmentation index in a multiple stepwise regression model. High-sensitivity C-reactive protein, a marker of systemic inflammation, is independently related to pulse wave velocity, a marker of aortic stiffness, and augmentation index, a manifestation of wave reflection, in essential hypertension. |
---|---|
AbstractList | The acute phase-reactant high-sensitivity C-reactive protein, a marker of vascular inflammation and an atherosclerotic risk factor, is related to arterial stiffness in healthy subjects and in systemic vasculitis. To explore the relationship between markers of inflammation, interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and high-sensitivity C-reactive protein with arterial stiffness, we studied untreated patients (n=78; 56% male; 47+/-1 years of age; mean+/-SEM) with essential hypertension. After overnight fast, augmentation index and pulse wave velocity were assessed noninvasively and related to plasma levels of inflammatory markers measured by ELISA. Pulse wave velocity was significantly related to plasma high-sensitivity C-reactive protein (r=0.31; P<0.001), TNF-alpha, (r=0.30; P<0.001) and IL-6 (r=0.21; P<0.05). There was also a relationship between heart rate-corrected augmentation index to high-sensitivity C-reactive protein (r=0.37; P<0.001), IL-6 (r=0.24; P<0.05), and TNF-alpha (r=0.19, P=0.06). High-sensitivity C-reactive protein was an independent predictor of pulse wave velocity and augmentation index in a multiple stepwise regression model. High-sensitivity C-reactive protein, a marker of systemic inflammation, is independently related to pulse wave velocity, a marker of aortic stiffness, and augmentation index, a manifestation of wave reflection, in essential hypertension. The acute phase–reactant high-sensitivity C-reactive protein, a marker of vascular inflammation and an atherosclerotic risk factor, is related to arterial stiffness in healthy subjects and in systemic vasculitis. To explore the relationship between markers of inflammation, interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and high-sensitivity C-reactive protein with arterial stiffness, we studied untreated patients (n=78; 56% male; 47±1 years of age; mean±SEM) with essential hypertension. After overnight fast, augmentation index and pulse wave velocity were assessed noninvasively and related to plasma levels of inflammatory markers measured by ELISA. Pulse wave velocity was significantly related to plasma high-sensitivity C-reactive protein ( r =0.31; P <0.001), TNF-α, ( r =0.30; P <0.001) and IL-6 ( r =0.21; P <0.05). There was also a relationship between heart rate–corrected augmentation index to high-sensitivity C-reactive protein ( r =0.37; P <0.001), IL-6 ( r =0.24; P <0.05), and TNF-α ( r =0.19, P =0.06). High-sensitivity C-reactive protein was an independent predictor of pulse wave velocity and augmentation index in a multiple stepwise regression model. High-sensitivity C-reactive protein, a marker of systemic inflammation, is independently related to pulse wave velocity, a marker of aortic stiffness, and augmentation index, a manifestation of wave reflection, in essential hypertension. The acute phase–reactant high-sensitivity C-reactive protein, a marker of vascular inflammation and an atherosclerotic risk factor, is related to arterial stiffness in healthy subjects and in systemic vasculitis. To explore the relationship between markers of inflammation, interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and high-sensitivity C-reactive protein with arterial stiffness, we studied untreated patients (n=78; 56% male; 47±1 years of age; mean±SEM) with essential hypertension. After overnight fast, augmentation index and pulse wave velocity were assessed noninvasively and related to plasma levels of inflammatory markers measured by ELISA. Pulse wave velocity was significantly related to plasma high-sensitivity C-reactive protein (r=0.31; P<0.001), TNF-α, (r=0.30; P<0.001) and IL-6 (r=0.21; P<0.05). There was also a relationship between heart rate–corrected augmentation index to high-sensitivity C-reactive protein (r=0.37; P<0.001), IL-6 (r=0.24; P<0.05), and TNF-α (r=0.19, P=0.06). High-sensitivity C-reactive protein was an independent predictor of pulse wave velocity and augmentation index in a multiple stepwise regression model. High-sensitivity C-reactive protein, a marker of systemic inflammation, is independently related to pulse wave velocity, a marker of aortic stiffness, and augmentation index, a manifestation of wave reflection, in essential hypertension. The acute phase-reactant high-sensitivity C-reactive protein, a marker of vascular inflammation and an atherosclerotic risk factor, is related to arterial stiffness in healthy subjects and in systemic vasculitis. To explore the relationship between markers of inflammation, interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and high-sensitivity C-reactive protein with arterial stiffness, we studied untreated patients (n=78; 56% male; 47+/-1 years of age; mean+/-SEM) with essential hypertension. After overnight fast, augmentation index and pulse wave velocity were assessed noninvasively and related to plasma levels of inflammatory markers measured by ELISA. Pulse wave velocity was significantly related to plasma high-sensitivity C-reactive protein (r=0.31; P<0.001), TNF-alpha, (r=0.30; P<0.001) and IL-6 (r=0.21; P<0.05). There was also a relationship between heart rate-corrected augmentation index to high-sensitivity C-reactive protein (r=0.37; P<0.001), IL-6 (r=0.24; P<0.05), and TNF-alpha (r=0.19, P=0.06). High-sensitivity C-reactive protein was an independent predictor of pulse wave velocity and augmentation index in a multiple stepwise regression model. High-sensitivity C-reactive protein, a marker of systemic inflammation, is independently related to pulse wave velocity, a marker of aortic stiffness, and augmentation index, a manifestation of wave reflection, in essential hypertension.The acute phase-reactant high-sensitivity C-reactive protein, a marker of vascular inflammation and an atherosclerotic risk factor, is related to arterial stiffness in healthy subjects and in systemic vasculitis. To explore the relationship between markers of inflammation, interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and high-sensitivity C-reactive protein with arterial stiffness, we studied untreated patients (n=78; 56% male; 47+/-1 years of age; mean+/-SEM) with essential hypertension. After overnight fast, augmentation index and pulse wave velocity were assessed noninvasively and related to plasma levels of inflammatory markers measured by ELISA. Pulse wave velocity was significantly related to plasma high-sensitivity C-reactive protein (r=0.31; P<0.001), TNF-alpha, (r=0.30; P<0.001) and IL-6 (r=0.21; P<0.05). There was also a relationship between heart rate-corrected augmentation index to high-sensitivity C-reactive protein (r=0.37; P<0.001), IL-6 (r=0.24; P<0.05), and TNF-alpha (r=0.19, P=0.06). High-sensitivity C-reactive protein was an independent predictor of pulse wave velocity and augmentation index in a multiple stepwise regression model. High-sensitivity C-reactive protein, a marker of systemic inflammation, is independently related to pulse wave velocity, a marker of aortic stiffness, and augmentation index, a manifestation of wave reflection, in essential hypertension. |
Author | Feely, John Mahmud, Azra |
AuthorAffiliation | From the Department of Therapeutics and Hypertension Clinic, Trinity Centre for Health Sciences, St. James’s Hospital, Dublin 8, Ireland |
AuthorAffiliation_xml | – name: From the Department of Therapeutics and Hypertension Clinic, Trinity Centre for Health Sciences, St. James’s Hospital, Dublin 8, Ireland |
Author_xml | – sequence: 1 givenname: Azra surname: Mahmud fullname: Mahmud, Azra organization: From the Department of Therapeutics and Hypertension Clinic, Trinity Centre for Health Sciences, St. James’s Hospital, Dublin 8, Ireland – sequence: 2 givenname: John surname: Feely fullname: Feely, John |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17255688$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/16216991$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkV9rFDEUxYNU7Lb6FWQQ9G3W3JkkM-OTpdTuQsFiFfQp3Jm9odFMZk2ylP32Zv_Ugk_m5ULu75yEc87YiZ88MfYG-BxAwXsO88WP2znPB1opVD2vmop3854_YzOQlSiFVPUJm3HoRNkBfD9lZzH-zLgQonnBTkFVoLoOZuz2IiQKFl1xl6wxnmIslrH4Qg4TrYo0FXfbmGi0Q7H0xuE4YrKTL6wvrmIkn3bSxXZN2cbHvHnJnht0kV4d5zn79unq6-WivPl8vby8uCkHmf9dVqKtSSoY-h7aWvKV7HrsuWqV6CWiQAKusEdoO4Om5o0kIxrJ802Dwgz1OXt38F2H6feGYtKjjQM5h56mTdSqbWpZdZDB10dw04-00utgRwxb_ZhBBt4eAYwDOhPQDzY-cU0lpWrbzH08cEOYYgxk9GDTPo0U0DoNXO_q0Rx0rkc_1aP39eieZ4sP_1j8feV_xOIgfphc7iz-cpsHCvqe0KX7vUJUqi0rziXALuOdB6__AIWxpFI |
CODEN | HPRTDN |
CitedBy_id | crossref_primary_10_1111_j_1524_6175_2007_07400_x crossref_primary_10_1093_ajh_hpt238 crossref_primary_10_1177_1759720X10384307 crossref_primary_10_1016_j_idairyj_2007_03_002 crossref_primary_10_1097_HJH_0000000000002678 crossref_primary_10_1177_1358863X14556695 crossref_primary_10_1902_jop_2009_097001 crossref_primary_10_1161_HYPERTENSIONAHA_110_163444 crossref_primary_10_1161_HYPERTENSIONAHA_120_16915 crossref_primary_10_1097_01_gme_0000243575_09065_48 crossref_primary_10_1186_s12872_022_02773_9 crossref_primary_10_1016_j_exger_2019_110650 crossref_primary_10_1016_j_artres_2012_09_003 crossref_primary_10_1016_j_trsl_2017_10_011 crossref_primary_10_1186_s12877_015_0089_x crossref_primary_10_1016_j_numecd_2008_07_006 crossref_primary_10_3389_fcvm_2023_1278795 crossref_primary_10_1016_j_amjcard_2008_10_004 crossref_primary_10_1016_j_lfs_2014_12_001 crossref_primary_10_1016_S1875_2136_08_70253_5 crossref_primary_10_1093_ajh_hpt103 crossref_primary_10_1111_j_1445_5994_2008_01811_x crossref_primary_10_14814_phy2_14920 crossref_primary_10_5551_jat_13516 crossref_primary_10_3389_fcvm_2022_818890 crossref_primary_10_1253_circj_CJ_11_1506 crossref_primary_10_1093_ndt_gfq806 crossref_primary_10_1007_s12170_008_0025_0 crossref_primary_10_1016_j_ijcard_2009_04_027 crossref_primary_10_3390_medicina57070653 crossref_primary_10_1080_13813455_2020_1764049 crossref_primary_10_1097_gme_0b013e31821f81c2 crossref_primary_10_1152_physrev_00003_2017 crossref_primary_10_2174_1871520623666230727095154 crossref_primary_10_1093_ajh_hpy145 crossref_primary_10_1364_BOE_457617 crossref_primary_10_1016_j_rmed_2009_09_004 crossref_primary_10_1038_sj_ejcn_1602886 crossref_primary_10_1093_ndt_gfk054 crossref_primary_10_1038_jhh_2010_23 crossref_primary_10_1016_j_artres_2009_09_001 crossref_primary_10_2169_internalmedicine_51_7701 crossref_primary_10_7600_jpfsm_1_205 crossref_primary_10_4103_tcmj_tcmj_60_24 crossref_primary_10_1016_j_ancard_2011_07_008 crossref_primary_10_1113_jphysiol_2006_111260 crossref_primary_10_1152_ajpheart_00043_2016 crossref_primary_10_1364_BOE_520551 crossref_primary_10_1111_ene_12332 crossref_primary_10_1016_j_atherosclerosis_2006_05_025 crossref_primary_10_2165_11593790_000000000_00000 crossref_primary_10_1016_j_cca_2007_06_009 crossref_primary_10_1038_jhh_2017_7 crossref_primary_10_1186_s12944_018_0671_2 crossref_primary_10_1053_j_semvascsurg_2015_04_003 crossref_primary_10_1016_j_artres_2007_03_005 crossref_primary_10_1093_ndt_gfl019 crossref_primary_10_1016_j_artres_2007_03_001 crossref_primary_10_1086_677370 crossref_primary_10_1111_jch_12533 crossref_primary_10_1109_JSEN_2016_2582805 crossref_primary_10_1111_jnc_14235 crossref_primary_10_3109_08037051_2010_532323 crossref_primary_10_1016_j_ymthe_2018_06_001 crossref_primary_10_1016_j_oraloncology_2020_104711 crossref_primary_10_1177_00033197211065795 crossref_primary_10_1080_10715762_2016_1201816 crossref_primary_10_1093_eurheartj_ehy310 crossref_primary_10_1016_j_hjc_2017_12_010 crossref_primary_10_1016_j_lfs_2017_03_016 crossref_primary_10_1253_circj_71_348 crossref_primary_10_1177_0003319712447888 crossref_primary_10_1053_j_ackd_2007_03_006 crossref_primary_10_1152_japplphysiol_00151_2014 crossref_primary_10_1016_j_amjcard_2009_05_002 crossref_primary_10_1111_jch_13297 crossref_primary_10_1016_j_vph_2018_12_005 crossref_primary_10_1038_ajh_2011_119 crossref_primary_10_1002_art_24521 crossref_primary_10_1097_01_hjh_0000249701_49854_21 crossref_primary_10_3109_10641963_2015_1081211 crossref_primary_10_1152_ajplung_00407_2020 crossref_primary_10_1016_j_atherosclerosis_2010_03_020 crossref_primary_10_1038_jhh_2011_59 crossref_primary_10_1007_s10741_019_09860_8 crossref_primary_10_1038_ki_2012_131 crossref_primary_10_1016_j_rvm_2016_12_001 crossref_primary_10_1038_sj_jhh_1002168 crossref_primary_10_1097_HJH_0000000000000444 crossref_primary_10_1097_HJH_0000000000001413 crossref_primary_10_1016_j_ejphar_2010_02_018 crossref_primary_10_1016_j_jash_2007_09_003 crossref_primary_10_1177_00033197211034267 crossref_primary_10_1007_s12170_010_0151_3 crossref_primary_10_1038_hr_2010_12 crossref_primary_10_1038_s41440_021_00716_z crossref_primary_10_1038_hr_2015_22 crossref_primary_10_3390_life12030397 crossref_primary_10_4178_epih_e2014005 crossref_primary_10_15421_022082 crossref_primary_10_1080_08164622_2021_1964332 crossref_primary_10_1038_s41569_019_0178_1 crossref_primary_10_1093_ajh_hpw209 crossref_primary_10_1093_ckj_sfae258 crossref_primary_10_1016_j_artres_2014_04_003 crossref_primary_10_1371_journal_pone_0183747 crossref_primary_10_3109_08037051_2014_940710 crossref_primary_10_1038_ajh_2010_246 crossref_primary_10_1016_j_ultrasmedbio_2017_04_026 crossref_primary_10_5551_jat_63801 crossref_primary_10_2147_VHRM_S294767 crossref_primary_10_1186_s12872_016_0268_5 crossref_primary_10_5494_wjh_v4_i1_1 crossref_primary_10_3899_jrheum_130520 crossref_primary_10_1038_s41371_021_00553_0 crossref_primary_10_1038_jhh_2015_105 crossref_primary_10_1111_j_1559_4564_2007_06006_x crossref_primary_10_1134_S2079057017010167 crossref_primary_10_1007_s00467_017_3660_1 crossref_primary_10_4070_kcj_2013_43_2_73 crossref_primary_10_1038_ajh_2009_132 crossref_primary_10_1016_j_ijcard_2008_08_005 crossref_primary_10_1111_j_1755_5922_2008_00051_x crossref_primary_10_15825_1995_1191_2024_3_117_123 crossref_primary_10_25040_aml2017_03_072 crossref_primary_10_1186_s40885_016_0039_8 crossref_primary_10_1111_nep_12859 crossref_primary_10_3389_fpubh_2020_600427 crossref_primary_10_3899_jrheum_130394 crossref_primary_10_1186_1476_9255_6_16 crossref_primary_10_1007_s11033_019_04690_1 crossref_primary_10_3390_jcm10143008 crossref_primary_10_1097_HJH_0b013e3280eec79f crossref_primary_10_1038_hr_2009_71 crossref_primary_10_1016_j_bbi_2020_09_001 crossref_primary_10_1080_17474086_2021_1959316 crossref_primary_10_1016_j_maturitas_2014_04_012 crossref_primary_10_1016_j_atherosclerosis_2010_12_023 crossref_primary_10_3390_antiox10122026 crossref_primary_10_3899_jrheum_131110 crossref_primary_10_1097_MNH_0b013e328335eec9 crossref_primary_10_1586_erc_11_140 crossref_primary_10_2170_physiolsci_RP010707 crossref_primary_10_1111_iji_12342 crossref_primary_10_1002_acr_22340 crossref_primary_10_3390_jcm11247311 crossref_primary_10_1016_j_atherosclerosis_2009_08_047 crossref_primary_10_1038_sj_jhh_1002244 crossref_primary_10_1038_sj_ejcn_1602577 crossref_primary_10_3889_oamjms_2016_011 crossref_primary_10_1093_ije_dyn374 crossref_primary_10_1515_jpem_2023_0530 crossref_primary_10_3390_ijms20163942 crossref_primary_10_1038_hr_2016_35 crossref_primary_10_1016_j_vph_2023_107214 crossref_primary_10_1111_1756_185X_14148 crossref_primary_10_1507_endocrj_EJ17_0117 crossref_primary_10_3109_17435390_2011_611915 crossref_primary_10_1161_JAHA_117_006535 crossref_primary_10_1097_HJH_0000000000002390 crossref_primary_10_1111_jch_13002 crossref_primary_10_4070_kcj_2007_37_7_312 crossref_primary_10_1080_08037050701464443 crossref_primary_10_3390_ijerph19053062 crossref_primary_10_1002_prp2_1189 crossref_primary_10_1161_ATVBAHA_116_308563 crossref_primary_10_1007_s00408_015_9804_9 crossref_primary_10_1111_j_1440_1681_2008_05062_x crossref_primary_10_1161_JAHA_120_017598 crossref_primary_10_3109_08860221003664280 crossref_primary_10_1016_j_atherosclerosis_2010_08_065 crossref_primary_10_1038_hr_2010_82 crossref_primary_10_1038_jhh_2009_8 crossref_primary_10_1038_jhh_2009_7 crossref_primary_10_1016_j_hfc_2011_08_002 crossref_primary_10_1007_s10659_020_09809_1 crossref_primary_10_1038_jhh_2013_17 crossref_primary_10_1016_j_diabet_2011_07_006 crossref_primary_10_1111_j_1751_7176_2008_00002_x crossref_primary_10_1038_hr_2009_91 crossref_primary_10_5551_jat_2741 crossref_primary_10_3390_nu12102982 crossref_primary_10_31083_j_fbl2909320 crossref_primary_10_5301_jbm_5000049 crossref_primary_10_1007_s11154_020_09616_y crossref_primary_10_1161_HYPERTENSIONAHA_120_15184 crossref_primary_10_3349_ymj_2012_53_2_258 crossref_primary_10_1038_jhh_2009_17 crossref_primary_10_1038_s41430_021_00870_0 crossref_primary_10_1111_j_1365_2125_2007_02980_x crossref_primary_10_1097_MBP_0b013e32832941ea crossref_primary_10_1097_HJH_0b013e3280a94e76 crossref_primary_10_1097_HJH_0b013e3282dc25da crossref_primary_10_1002_ptr_6046 crossref_primary_10_1186_s12950_014_0029_0 crossref_primary_10_1093_ckj_sfx120 crossref_primary_10_1186_s12872_021_02180_6 crossref_primary_10_1155_2017_9632846 crossref_primary_10_1093_ajh_hpw134 crossref_primary_10_2174_1570161120666220201160038 crossref_primary_10_1111_j_1472_8206_2008_00584_x crossref_primary_10_1161_JAHA_118_010329 crossref_primary_10_1002_dmrr_3495 crossref_primary_10_1007_s00439_007_0349_8 crossref_primary_10_1177_0004563217733286 crossref_primary_10_3389_fcvm_2021_709396 crossref_primary_10_1016_j_jash_2016_07_006 crossref_primary_10_1186_s13063_019_3690_z crossref_primary_10_1097_HJH_0b013e32833ca68c crossref_primary_10_1016_j_bspc_2012_03_001 crossref_primary_10_1097_00029330_200607020_00016 crossref_primary_10_1007_s40520_019_01274_8 crossref_primary_10_1002_ijc_30839 crossref_primary_10_1902_jop_2009_080471 crossref_primary_10_1186_s12891_016_1201_x crossref_primary_10_1161_CIRCRESAHA_115_306656 crossref_primary_10_1097_FJC_0000000000000017 crossref_primary_10_1016_j_bbi_2007_04_003 crossref_primary_10_2147_IJGM_S353276 crossref_primary_10_1161_JAHA_116_004987 crossref_primary_10_1364_BOE_557984 crossref_primary_10_17116_terarkh201688593_101 crossref_primary_10_1152_ajpregu_00168_2006 crossref_primary_10_1093_ajh_hpx007 crossref_primary_10_1016_j_bbi_2008_01_009 crossref_primary_10_2991_artres_k_191114_002 crossref_primary_10_1159_000374095 crossref_primary_10_1152_ajpheart_00287_2022 crossref_primary_10_1016_j_envres_2018_02_008 crossref_primary_10_1111_j_1524_6175_2006_06032_x crossref_primary_10_1016_j_smrv_2012_03_002 crossref_primary_10_1152_ajpheart_00328_2013 crossref_primary_10_1016_j_ijcard_2022_02_033 crossref_primary_10_2337_dc11_1475 |
Cites_doi | 10.1161/01.cir.0000033824.02722.f7 10.1016/j.atherosclerosis.2004.04.014 10.1038/sj.jhh.1001786 10.1016/j.metabol.2004.05.013 10.1056/NEJMoa040967 10.1161/01.str.0000130422.89335.81 10.1161/01.CIR.0000105767.94169.E3 10.1111/j.1469-7793.2000.t01-1-00263.x 10.3317/jraas.2004.025 10.1097/00004872-200402000-00019 10.1016/S0895-7061(01)02313-5 10.1161/circ.102.9.1000 10.1046/j.1365-2125.2002.1528adoc.x 10.1038/sj.jhh.1001785 10.1161/circ.102.9.994 10.1016/j.cpcardiol.2004.03.004 10.1210/jc.2003-032103 10.1081/CEH-200031959 10.1056/NEJMoa042378 10.1097/00004872-199917020-00008 10.1161/hyp.38.3.434 10.1161/01.str.0000099124.84425.bb 10.1161/atvb.19.4.972 10.1161/01.hyp.0000111829.46090.92 10.1016/S0021-9150(03)00158-8 10.1161/hyp.38.3.399 10.1016/S0895-7061(00)01320-0 10.1002/art.20002 10.1016/j.amjhyper.2003.12.002 10.1161/hyp.37.5.1236 10.1161/01.atv.0000151373.33830.41 10.1161/01.atv.zhq0504.0173 |
ContentType | Journal Article |
Copyright | 2005 American Heart Association, Inc. 2006 INIST-CNRS |
Copyright_xml | – notice: 2005 American Heart Association, Inc. – notice: 2006 INIST-CNRS |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1161/01.HYP.0000185463.27209.b0 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1524-4563 |
EndPage | 1122 |
ExternalDocumentID | 16216991 17255688 10_1161_01_HYP_0000185463_27209_b0 00004268-200511000-00010 |
Genre | Journal Article |
GroupedDBID | --- .-D .3C .55 .GJ .XZ .Z2 01R 0R~ 18M 1J1 2WC 3O- 40H 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 71W 77Y 7O~ AAAAV AAAXR AAFWJ AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AARTV AASCR AASOK AAXQO AAYEP ABASU ABBUW ABDIG ABJNI ABOCM ABPXF ABQRW ABVCZ ABXVJ ABXYN ABZAD ABZZY ACCJW ACDDN ACEWG ACGFO ACGFS ACILI ACLDA ACWDW ACWRI ACXJB ACXNZ ACZKN ADBBV ADFPA ADGGA ADHPY ADNKB AE3 AE6 AEBDS AEETU AENEX AFBFQ AFDTB AFEXH AFFNX AFNMH AFUWQ AGINI AHMBA AHOMT AHQNM AHQVU AHRYX AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJNYG AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC BAWUL BCGUY BOYCO BQLVK BS7 C1A C45 CS3 DIK DIWNM DUNZO E.X E3Z EBS EEVPB EJD ERAAH EX3 F2K F2L F2M F2N F5P FCALG FL- FW0 GNXGY GQDEL GX1 H0~ H13 HLJTE HZ~ IKREB IKYAY IN~ IPNFZ JF9 JG8 JK3 JK8 K-A K-F K8S KD2 KMI KQ8 L-C L7B N4W N9A N~7 N~B N~M O9- OAG OAH OB3 OCUKA ODA ODMTH OGROG OHYEH OK1 OL1 OLG OLH OLU OLV OLY OLZ OPUJH ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OWBYB OWU OWV OWW OWX OWY OWZ OXXIT P-K P2P PQQKQ R58 RAH RIG RLZ S4R S4S T8P TEORI TR2 TSPGW V2I VVN W3M W8F WH7 WOQ WOW X3V X3W X7M XXN XYM YFH YHZ YOC YYM YYP ZFV ZGI ZZMQN AAYXX ADGHP CITATION IQODW OZ- ACIJW AWKKM CGR CUY CVF ECM EIF NPM OLW RHF 7X8 |
ID | FETCH-LOGICAL-c5000-2483e561cbb18350d59bab06864b5aa4ae106aba189faf3075ef4750ba17a4fc3 |
ISSN | 0194-911X 1524-4563 |
IngestDate | Thu Aug 07 15:12:50 EDT 2025 Wed Feb 19 01:42:27 EST 2025 Mon Jul 21 09:16:54 EDT 2025 Thu Apr 24 23:04:35 EDT 2025 Tue Jul 01 04:30:38 EDT 2025 Fri May 16 03:51:29 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Keywords | Human Hypertension Scanning electron microscopy Elasticity arteries Cardiovascular disease Inflammation hypertension, arterial Endothelium Vascular disease Interleukin 6 Heart rate Tumor necrosis factor Atherosclerosis Risk factor Aorta Stiffness C reactive protein |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c5000-2483e561cbb18350d59bab06864b5aa4ae106aba189faf3075ef4750ba17a4fc3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 16216991 |
PQID | 68735291 |
PQPubID | 23479 |
PageCount | 5 |
ParticipantIDs | proquest_miscellaneous_68735291 pubmed_primary_16216991 pascalfrancis_primary_17255688 crossref_citationtrail_10_1161_01_HYP_0000185463_27209_b0 crossref_primary_10_1161_01_HYP_0000185463_27209_b0 wolterskluwer_health_00004268-200511000-00010 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2005-November |
PublicationDateYYYYMMDD | 2005-11-01 |
PublicationDate_xml | – month: 11 year: 2005 text: 2005-November |
PublicationDecade | 2000 |
PublicationPlace | Philadelphia, PA Hagerstown, MD |
PublicationPlace_xml | – name: Philadelphia, PA – name: Hagerstown, MD – name: United States |
PublicationTitle | Hypertension (Dallas, Tex. 1979) |
PublicationTitleAlternate | Hypertension |
PublicationYear | 2005 |
Publisher | American Heart Association, Inc Lippincott |
Publisher_xml | – name: American Heart Association, Inc – name: Lippincott |
References | e_1_3_1_21_2 e_1_3_1_22_2 e_1_3_1_23_2 e_1_3_1_24_2 e_1_3_1_8_2 e_1_3_1_7_2 e_1_3_1_9_2 e_1_3_1_20_2 e_1_3_1_4_2 e_1_3_1_29_2 e_1_3_1_3_2 e_1_3_1_6_2 e_1_3_1_5_2 e_1_3_1_25_2 e_1_3_1_26_2 e_1_3_1_2_2 e_1_3_1_27_2 e_1_3_1_1_2 e_1_3_1_28_2 (e_1_3_1_12_2) 2005; 22 e_1_3_1_32_2 e_1_3_1_33_2 e_1_3_1_13_2 e_1_3_1_11_2 e_1_3_1_30_2 e_1_3_1_10_2 e_1_3_1_31_2 e_1_3_1_17_2 e_1_3_1_16_2 e_1_3_1_15_2 e_1_3_1_14_2 e_1_3_1_19_2 e_1_3_1_18_2 |
References_xml | – ident: e_1_3_1_2_2 doi: 10.1161/01.cir.0000033824.02722.f7 – ident: e_1_3_1_26_2 doi: 10.1016/j.atherosclerosis.2004.04.014 – ident: e_1_3_1_31_2 doi: 10.1038/sj.jhh.1001786 – ident: e_1_3_1_32_2 doi: 10.1016/j.metabol.2004.05.013 – ident: e_1_3_1_9_2 doi: 10.1056/NEJMoa040967 – ident: e_1_3_1_7_2 doi: 10.1161/01.str.0000130422.89335.81 – ident: e_1_3_1_5_2 doi: 10.1161/01.CIR.0000105767.94169.E3 – ident: e_1_3_1_14_2 doi: 10.1111/j.1469-7793.2000.t01-1-00263.x – ident: e_1_3_1_20_2 doi: 10.3317/jraas.2004.025 – ident: e_1_3_1_8_2 doi: 10.1097/00004872-200402000-00019 – ident: e_1_3_1_27_2 doi: 10.1016/S0895-7061(01)02313-5 – ident: e_1_3_1_22_2 doi: 10.1161/circ.102.9.1000 – ident: e_1_3_1_25_2 doi: 10.1046/j.1365-2125.2002.1528adoc.x – ident: e_1_3_1_10_2 doi: 10.1038/sj.jhh.1001785 – ident: e_1_3_1_21_2 doi: 10.1161/circ.102.9.994 – ident: e_1_3_1_24_2 doi: 10.1016/j.cpcardiol.2004.03.004 – ident: e_1_3_1_30_2 doi: 10.1210/jc.2003-032103 – ident: e_1_3_1_15_2 doi: 10.1081/CEH-200031959 – ident: e_1_3_1_33_2 doi: 10.1056/NEJMoa042378 – volume: 22 start-page: 1133 year: 2005 ident: e_1_3_1_12_2 publication-title: J Hypertens – ident: e_1_3_1_3_2 doi: 10.1097/00004872-199917020-00008 – ident: e_1_3_1_4_2 doi: 10.1161/hyp.38.3.434 – ident: e_1_3_1_29_2 doi: 10.1161/01.str.0000099124.84425.bb – ident: e_1_3_1_17_2 doi: 10.1161/atvb.19.4.972 – ident: e_1_3_1_18_2 doi: 10.1161/01.hyp.0000111829.46090.92 – ident: e_1_3_1_28_2 doi: 10.1016/S0021-9150(03)00158-8 – ident: e_1_3_1_6_2 doi: 10.1161/hyp.38.3.399 – ident: e_1_3_1_16_2 doi: 10.1016/S0895-7061(00)01320-0 – ident: e_1_3_1_13_2 doi: 10.1002/art.20002 – ident: e_1_3_1_23_2 doi: 10.1016/j.amjhyper.2003.12.002 – ident: e_1_3_1_1_2 doi: 10.1161/hyp.37.5.1236 – ident: e_1_3_1_19_2 doi: 10.1161/01.atv.0000151373.33830.41 – ident: e_1_3_1_11_2 doi: 10.1161/01.atv.zhq0504.0173 |
SSID | ssj0014447 |
Score | 2.3507981 |
Snippet | The acute phase–reactant high-sensitivity C-reactive protein, a marker of vascular inflammation and an atherosclerotic risk factor, is related to arterial... The acute phase-reactant high-sensitivity C-reactive protein, a marker of vascular inflammation and an atherosclerotic risk factor, is related to arterial... |
SourceID | proquest pubmed pascalfrancis crossref wolterskluwer |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1118 |
SubjectTerms | Arterial hypertension. Arterial hypotension Arteries - physiopathology Biological and medical sciences Biomarkers - blood Blood and lymphatic vessels Blood Flow Velocity C-Reactive Protein - metabolism Cardiology. Vascular system Clinical manifestations. Epidemiology. Investigative techniques. Etiology Cross-Sectional Studies Elasticity Experimental diseases Female Humans Hypertension - complications Inflammation - blood Inflammation - etiology Inflammation - physiopathology Interleukin-6 - blood Male Medical sciences Middle Aged Pulse Tumor Necrosis Factor-alpha - metabolism |
Title | Arterial Stiffness Is Related to Systemic Inflammation in Essential Hypertension |
URI | https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00004268-200511000-00010 https://www.ncbi.nlm.nih.gov/pubmed/16216991 https://www.proquest.com/docview/68735291 |
Volume | 46 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zj9MwELZgkRASQtyUY8kDbyglTmwnfqzYrsJRtA9bqftk2aktIlC7arra1f56xkeOoiIWXqLWrXN4JuNvxvONEXqnWVaBLwveCa3AQUllHgOqxnFKwSKnyoJWy0aefWPlnHxe0EXPPXHskq0aV9d7eSX_I1VoA7laluw_SLY7KTTAZ5AvHEHCcLyRjCc2H9MzPmpjnNGqG09PARwJqNLXaa4rm3MFovc0RVclpLGkI9v1OziiG5fGHgQUkGo5aLcw9MhG3H1Okb4av8c854MowmxSzuZHztBcbzpLfzydfj3bSfht4ws0EO26-EJXJ2IYheTEWsnF0IyGSGI9XKh2NhGsaTGYXwHgpfttN8OOjzAuz05cWUmAEoRlY7tSzMcq6WesdpX-t4msSy8EUGYLqxW30Z00z_3q_acv3eISISSw6P1ThFq0cP0Pf776Dm65fy4beIWM3_tkn3MC_7lc23yH5oejOwxAy-lD9CB4G9HEq84jdEuvHqO7s5BP8QSdtBoUdRoU1U0UNCjarqNWg6KhBsGXqNOgaKhBT9H8eHr6sYzDHhtxZbfCiFNSZBowdKUUGHeaLClXUlneEFFUSiI1TphUEhfcSAMTAtWGAMqEllwSU2XP0MFqvdIvUKRMCmjWYJ1jA25wVihCNFvyJRj5RDE-QrwdQVGFAvR2H5SfwjmiDIsECxh90Y--cKMvVDJCWdf33JdhuVGvwx1B9V2DgozQ21ZyAsyqXSuTK72-aASDB6ApxyP03Au078tSzLj9Jd6RsPDEZXcfAHudpaK2IKOr3ICTl3-7mVfoXv_-vUYH282FfgOId6sOnf7-Aq8Zovo |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Arterial+stiffness+is+related+to+systemic+inflammation+in+essential+hypertension&rft.jtitle=Hypertension+%28Dallas%2C+Tex.+1979%29&rft.au=MAHMUD%2C+Azra&rft.au=FEELY%2C+John&rft.date=2005-11-01&rft.pub=Lippincott&rft.issn=0194-911X&rft.volume=46&rft.issue=5&rft.spage=1118&rft.epage=1122&rft_id=info:doi/10.1161%2F01.HYP.0000185463.27209.b0&rft.externalDBID=n%2Fa&rft.externalDocID=17255688 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0194-911X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0194-911X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0194-911X&client=summon |